Cargando…
Bile Acid and Fibroblast Growth Factor 19 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Sleeve Gastrectomy
Background: Sleeve gastrectomy (SG) is an effective treatment for obesity and type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD); however, the mechanism is not completely understood. Bile acids and fibroblast growth factors (FGFs) are involved in the regulation of energy...
Autores principales: | Huang, Hsien-Hao, Lee, Wei-Jei, Chen, Shu-Chun, Chen, Tung-Fang, Lee, Shou-Dong, Chen, Chih-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616896/ https://www.ncbi.nlm.nih.gov/pubmed/31181641 http://dx.doi.org/10.3390/jcm8060815 |
Ejemplares similares
-
Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass
por: Guo, Jiun-Yu, et al.
Publicado: (2022) -
Improvement of non‐alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients
por: Endo, Yuichi, et al.
Publicado: (2019) -
Outcomes of primary sleeve gastrectomy versus conversion sleeve gastrectomy in morbidly obese patients
por: Park, Jong Seob, et al.
Publicado: (2019) -
Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
por: Pei, Erli, et al.
Publicado: (2018) -
Ultra-Early and Early Changes in Bile Acids and Insulin after Sleeve Gastrectomy among Obese Patients
por: Cӑtoi, Adriana Florinela, et al.
Publicado: (2019)